annual shareholders equity:
$46.38B-$1.68B(-3.50%)Summary
- As of today (August 16, 2025), TAK annual stockholders equity is $46.38 billion, with the most recent change of -$1.68 billion (-3.50%) on March 1, 2025.
- During the last 3 years, TAK annual shareholders equity has fallen by -$445.88 million (-0.95%).
- TAK annual shareholders equity is now -3.50% below its all-time high of $48.06 billion, reached on March 31, 2024.
Performance
TAK Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$47.53B+$1.15B(+2.48%)Summary
- As of today (August 16, 2025), TAK quarterly stockholders equity is $47.53 billion, with the most recent change of +$1.15 billion (+2.48%) on June 1, 2025.
- Over the past year, TAK quarterly shareholders equity has dropped by -$945.93 million (-1.95%).
- TAK quarterly shareholders equity is now -1.95% below its all-time high of $48.47 billion, reached on June 30, 2024.
Performance
TAK quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
TAK Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.5% | -1.9% |
| 3 y3 years | -0.9% | +2.8% |
| 5 y5 years | +6.0% | +9.1% |
TAK Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.5% | at low | -1.9% | +2.8% |
| 5 y | 5-year | -3.5% | +6.0% | -1.9% | +9.1% |
| alltime | all time | -3.5% | +1173.1% | -1.9% | +188.5% |
TAK Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $47.53B(+2.5%) |
| Mar 2025 | $46.38B(-3.5%) | $46.38B(-1.7%) |
| Dec 2024 | - | $47.20B(-2.4%) |
| Sep 2024 | - | $48.38B(-0.2%) |
| Jun 2024 | - | $48.47B(+0.9%) |
| Mar 2024 | $48.06B(+0.7%) | $48.06B(+0.5%) |
| Dec 2023 | - | $47.82B(+0.9%) |
| Sep 2023 | - | $47.38B(-1.1%) |
| Jun 2023 | - | $47.88B(+0.3%) |
| Mar 2023 | $47.74B(+2.0%) | $47.74B(+2.0%) |
| Dec 2022 | - | $46.81B(+0.9%) |
| Sep 2022 | - | $46.38B(+0.3%) |
| Jun 2022 | - | $46.25B(-0.7%) |
| Mar 2022 | $46.82B(+0.0%) | $46.56B(+0.5%) |
| Dec 2021 | - | $46.33B(-2.6%) |
| Sep 2021 | - | $47.56B(+0.4%) |
| Jun 2021 | - | $47.39B(+1.0%) |
| Mar 2021 | $46.81B(+7.0%) | $46.89B(+4.3%) |
| Dec 2020 | - | $44.94B(+1.9%) |
| Sep 2020 | - | $44.12B(+1.3%) |
| Jun 2020 | - | $43.56B(-0.3%) |
| Mar 2020 | $43.75B(-6.5%) | $43.71B(-2.3%) |
| Dec 2019 | - | $44.74B(-0.7%) |
| Sep 2019 | - | $45.07B(-0.1%) |
| Jun 2019 | - | $45.14B(-3.4%) |
| Mar 2019 | $46.82B(+149.3%) | $46.74B(+153.0%) |
| Dec 2018 | - | $18.47B(-3.1%) |
| Sep 2018 | - | $19.07B(+3.2%) |
| Jun 2018 | - | $18.49B(-1.6%) |
| Mar 2018 | $18.78B(+10.5%) | $18.80B(+0.2%) |
| Dec 2017 | - | $18.75B(+1.1%) |
| Sep 2017 | - | $18.54B(+3.1%) |
| Jun 2017 | - | $17.98B(+6.1%) |
| Mar 2017 | $17.00B(-2.0%) | $16.94B(-0.6%) |
| Dec 2016 | - | $17.04B(-5.2%) |
| Sep 2016 | - | $17.97B(+2.2%) |
| Jun 2016 | - | $17.59B(+1.5%) |
| Mar 2016 | $17.34B(-2.7%) | $17.34B(-0.5%) |
| Dec 2015 | - | $17.42B(-1.5%) |
| Sep 2015 | - | $17.68B(+0.2%) |
| Jun 2015 | - | $17.65B(-0.9%) |
| Mar 2015 | $17.82B(-25.7%) | $17.80B(-15.0%) |
| Dec 2014 | - | $20.95B(-7.0%) |
| Sep 2014 | - | $22.52B(-4.4%) |
| Jun 2014 | - | $23.55B(-1.9%) |
| Mar 2014 | $23.99B(-0.8%) | $24.01B(+5.7%) |
| Dec 2013 | - | $22.71B(-2.6%) |
| Sep 2013 | - | $23.33B(+3.9%) |
| Jun 2013 | - | $22.46B(-7.0%) |
| Mar 2013 | $24.19B | $24.15B(+0.7%) |
| Dec 2012 | - | $23.98B(-2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $24.64B(+3.4%) |
| Jun 2012 | - | $23.83B(-6.9%) |
| Mar 2012 | $24.45B(-3.1%) | $25.60B(+3.8%) |
| Dec 2011 | - | $24.67B(-4.7%) |
| Sep 2011 | - | $25.90B(+0.9%) |
| Jun 2011 | - | $25.66B(+2.1%) |
| Mar 2011 | $25.24B(+11.2%) | $25.14B(+0.1%) |
| Dec 2010 | - | $25.13B(+1.8%) |
| Sep 2010 | - | $24.68B(+7.0%) |
| Jun 2010 | - | $23.06B(+1.7%) |
| Mar 2010 | $22.70B(+11.5%) | $22.68B(+2.2%) |
| Dec 2009 | - | $22.18B(-2.5%) |
| Sep 2009 | - | $22.75B(+5.5%) |
| Jun 2009 | - | $21.57B(+6.2%) |
| Mar 2009 | $20.36B(-11.1%) | $20.32B(-1.8%) |
| Dec 2008 | - | $20.68B(+0.2%) |
| Sep 2008 | - | $20.64B(+0.9%) |
| Jun 2008 | - | $20.45B(-12.3%) |
| Mar 2008 | $22.91B(+11.8%) | - |
| Mar 2008 | - | $23.33B(+5.7%) |
| Dec 2007 | - | $22.08B(+3.9%) |
| Sep 2007 | - | $21.24B(+2.6%) |
| Jun 2007 | - | $20.70B(-0.7%) |
| Mar 2007 | $20.50B(+3.0%) | - |
| Mar 2007 | - | $20.84B(+4.0%) |
| Dec 2006 | - | $20.04B(-0.5%) |
| Sep 2006 | - | $20.14B(-3.5%) |
| Jun 2006 | - | $20.87B(+2.8%) |
| Mar 2006 | $19.90B(+6.4%) | - |
| Mar 2006 | - | $20.30B(+1.8%) |
| Dec 2005 | - | $19.95B(+0.3%) |
| Sep 2005 | - | $19.88B(+2.9%) |
| Jun 2005 | - | $19.32B(+1.0%) |
| Mar 2005 | $18.71B(+9.3%) | - |
| Mar 2005 | - | $19.13B(+16.1%) |
| Dec 2004 | - | $16.48B(-8.1%) |
| Sep 2004 | - | $17.93B(+3.3%) |
| Jun 2004 | - | $17.35B |
| Mar 2004 | $17.12B(+29.5%) | - |
| Mar 2003 | $13.22B(+23.4%) | - |
| Mar 2002 | $10.71B(+10.7%) | - |
| Mar 2001 | $9.68B(+1.9%) | - |
| Mar 2000 | $9.50B(+25.9%) | - |
| Mar 1999 | $7.54B(+22.4%) | - |
| Mar 1998 | $6.16B(+1.7%) | - |
| Mar 1997 | $6.06B(-6.2%) | - |
| Mar 1996 | $6.45B(-13.6%) | - |
| Mar 1995 | $7.47B(+26.1%) | - |
| Mar 1994 | $5.92B(+18.0%) | - |
| Mar 1993 | $5.02B(+24.1%) | - |
| Mar 1992 | $4.04B(+11.0%) | - |
| Mar 1991 | $3.64B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual stockholders equity?
- What is the all time high annual shareholders equity for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual shareholders equity year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly shareholders equity year-on-year change?
What is Takeda Pharmaceutical Company Limited annual stockholders equity?
The current annual shareholders equity of TAK is $46.38B
What is the all time high annual shareholders equity for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual stockholders equity is $48.06B
What is Takeda Pharmaceutical Company Limited annual shareholders equity year-on-year change?
Over the past year, TAK annual stockholders equity has changed by -$1.68B (-3.50%)
What is Takeda Pharmaceutical Company Limited quarterly stockholders equity?
The current quarterly shareholders equity of TAK is $47.53B
What is the all time high quarterly shareholders equity for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly stockholders equity is $48.47B
What is Takeda Pharmaceutical Company Limited quarterly shareholders equity year-on-year change?
Over the past year, TAK quarterly stockholders equity has changed by -$945.93M (-1.95%)